Results 31 to 40 of about 94,635 (266)

Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis

open access: yesArthritis Research & Therapy, 2017
Background Microscopic polyangiitis (MPA), which is classified as an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis, is one of the most frequent primary vasculitides in Japan.
Akihiro Ishizu   +18 more
doaj   +1 more source

Depressive symptoms among patients with schizophrenia in acute and remission phases [PDF]

open access: yesVojnosanitetski Pregled, 2018
Bacground/Aim. Researchers suggest that among people with schizophrenia, the prevalence of depressive symptoms ranges from 7% to 80%. The rate of depressive symptoms among people with schizophrenia varies widely because of the phase of the disease, type ...
Peljto Amir   +3 more
doaj   +1 more source

Experience with FLT3 Inhibitor Midostaurin in Newly Diagnosed Acute Myeloid Leukemia Patients

open access: yesTurkish Journal of Internal Medicine, 2021
Introduction With the introduction of FLT3 inhibitors in recent years, the presence of FLT3 mutation in newly diagnosed acute myeloid leukemia (AML) patients has become more important.
Mehmet Baysal, Nihan Alkis, Serap Baysal
doaj   +1 more source

Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study

open access: yesRheumatology & Autoimmunity, 2021
Background Subjective residual symptoms persist after clinical remission of rheumatoid arthritis (RA) in Japanese patients. Few studies have examined the relationship between these symptoms and subclinical inflammation using high‐sensitivity imaging ...
Masao Nawata   +6 more
doaj   +1 more source

Post-Induction Remission Status in B-Acute Lymphoblastic Leukemia Patients (B-ALL),  Experience at Tertiary Care Hospital

open access: yesPakistan Armed Forces Medical Journal
Objectives: To determine the frequency of post-induction remission status and its association with cytogenetic and molecular abnormalities in patients with B-ALL. Study Design: Cross-sectional Analytical study.
Sumaira Ilyas   +5 more
doaj   +1 more source

Favorable subset of acute myeloid leukemia with translocation 8;21: An elusive experience

open access: yesMuller Journal of Medical Sciences and Research, 2015
Background: Risk stratification is critical in the management of acute myeloid leukemia (AML) and among the favorable subset translocations known, 8;21 seems elusive in our clinical practice as regards the response remission status. This led us to review
Nusrat Bashir Khan   +5 more
doaj   +1 more source

CLIPPERS: Induction and maintenance of remission using hydroxychloroquine [PDF]

open access: yesNeurology Neuroimmunology & Neuroinflammation, 2015
Chronic lymphocytic inflammation and pontine perivascular enhancement responsive to steroids (CLIPPERS) is a condition that was first described by Pittock et al.1 in 2010 and is characterized by brainstem symptoms, gait ataxia, and diplopia. Brain MRIs of patients demonstrate punctate or nodular gadolinium-enhancing lesions in the pons.
Tan, Boon Loong   +2 more
openaire   +2 more sources

Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study

open access: yesImmunological Medicine
Rituximab (RTX) has been reported to effectively maintain remission in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). In this multicenter study involving 57 patients who achieved remission after 24 weeks, we evaluated the effectiveness
Chie Ogita   +34 more
doaj   +1 more source

Central Nervous System Neuroblastoma, FOXR2‐Activated: A Pooled Analysis of Published Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) neuroblastoma, FOXR2‐activated, is a recently recognized entity in the WHO CNS5 classification, defined by activation of the FOXR2 transcription factor and unique histopathological features. This review synthesizes available literature and pooled clinical data, providing insight into demographics ...
Sudarshawn Damodharan   +1 more
wiley   +1 more source

Role of the intensive care in treatment of patients with acute myeloid leukemia

open access: yesТерапевтический архив, 2019
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts).
A V Bazhenov   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy